Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer

Patients with previously untreated extensive-disease small-cell lung cancer were treated with irinotecan 60 mg m(−2) on days 1 and 8 and cisplatin 60 mg m(−2) on day 1 with (n=55) or without (n=54) etoposide 50 mg m(−2) on days 1–3 with granulocyte colony-stimulating factor support repeated every 3...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Sekine, I, Nokihara, H, Takeda, K, Nishiwaki, Y, Nakagawa, K, Isobe, H, Mori, K, Matsui, K, Saijo, N, Tamura, T
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2008
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2259188/
https://ncbi.nlm.nih.gov/pubmed/18253118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604233
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items